Evidence map›Paper›PMID 36231032›Full record

ArticleCells2022

Effects of Endochondral and Intramembranous Ossification Pathways on Bone Tissue Formation and Vascularization in Human Tissue-Engineered Grafts.

Jonathan C Bernhard, Darja Marolt Presen, Ming Li, Xavier Monforte, James Ferguson, Gabriele Leinfellner, Patrick Heimel, Susanna L Betti, Sharon Shu, Andreas H Teuschl-Woller and 3 more

Abstract read
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Cartilage-SpecificBiomedicines · 2025
    Article
  7. Review
  8. Review
  9. Role of Adipose-Derived Mesenchymal Stem Cells in Bone Regeneration.International journal of molecular sciences · 2024
    Review
  10. Review
  11. Stem Cells and Bone Tissue Engineering.Life (Basel, Switzerland) · 2024
    Review
  12. Review
  13. The Role of Gli1Biomolecules · 2023
    Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jonathan C BernhardDepartment of Biomedical Engineering, Columbia University, New York, NY 10032, USA.
Darja Marolt PresenLudwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA, 1200 Vienna, Austria.
Ming LiDepartment of Biomedical Engineering, Columbia University, New York, NY 10032, USA.
Xavier MonforteAustrian Cluster for Tissue Regeneration, 1200 Vienna, Austria.
James FergusonLudwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA, 1200 Vienna, Austria.
Gabriele LeinfellnerLudwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA, 1200 Vienna, Austria.
Patrick HeimelLudwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA, 1200 Vienna, Austria.ORCID 0000-0002-2499-325X
Susanna L BettiDepartment of Biomedical Engineering, Columbia University, New York, NY 10032, USA.ORCID 0000-0003-4973-0648
Sharon ShuDepartment of Biomedical Engineering, Columbia University, New York, NY 10032, USA.
Andreas H Teuschl-WollerAustrian Cluster for Tissue Regeneration, 1200 Vienna, Austria.ORCID 0000-0002-3817-1572
Stefan TanglAustrian Cluster for Tissue Regeneration, 1200 Vienna, Austria.ORCID 0000-0002-9023-4745
Heinz RedlLudwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA, 1200 Vienna, Austria.ORCID 0000-0003-1654-462X
Gordana Vunjak-NovakovicDepartment of Biomedical Engineering, Columbia University, New York, NY 10032, USA.

Funding

Tissue Engineering Resource Center: TTDP41EB027062 · NIBIB · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Gordana Vunjak-Novakovic · 2019 to 2026
$12.6M
NIBIB NIH HHS P41 EB027062
6 · The paper itself

Abstract

Bone grafts can be engineered by differentiating human mesenchymal stromal cells (MSCs) via the endochondral and intramembranous ossification pathways. We evaluated the effects of each pathway on the properties of engineered bone grafts and their capacity to drive bone regeneration. Bone-marrow-derived MSCs were differentiated on silk scaffolds into either hypertrophic chondrocytes (hyper) or osteoblasts (osteo) over 5 weeks of in vitro cultivation, and were implanted subcutaneously for 12 weeks. The pathways' constructs were evaluated over time with respect to gene expression, composition, histomorphology, microstructure, vascularization and biomechanics. Hypertrophic chondrocytes expressed higher levels of osteogenic genes and deposited significantly more bone mineral and proteins than the osteoblasts. Before implantation, the mineral in the hyper group was less mature than that in the osteo group. Following 12 weeks of implantation, the hyper group had increased mineral density but a similar overall mineral composition compared with the osteo group. The hyper group also displayed significantly more blood vessel infiltration than the osteo group. Both groups contained M2 macrophages, indicating bone regeneration. These data suggest that, similar to the body's repair processes, endochondral pathway might be more advantageous when regenerating large defects, whereas intramembranous ossification could be utilized to guide the tissue formation pattern with a scaffold architecture.

Indexed as

Mesenchymal Stem CellsOsteogenesisBone and BonesHumansNeovascularization, PathologicSilkTissue EngineeringSilkbone tissue engineeringendochondralintramembranousmesenchymal stromal cellsossification

Identifiers

PMID36231032
PMCPMC9564153

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.